191 related articles for article (PubMed ID: 28865121)
1. HNF1A/CASC2 regulates pancreatic cancer cell proliferation through PTEN/Akt signaling.
Yu Y; Liang S; Zhou Y; Li S; Li Y; Liao W
J Cell Biochem; 2019 Mar; 120(3):2816-2827. PubMed ID: 28865121
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte nuclear factor 1A (HNF1A) as a possible tumor suppressor in pancreatic cancer.
Luo Z; Li Y; Wang H; Fleming J; Li M; Kang Y; Zhang R; Li D
PLoS One; 2015; 10(3):e0121082. PubMed ID: 25793983
[TBL] [Abstract][Full Text] [Related]
3. LncRNA CASC2 Interacts With miR-181a to Modulate Glioma Growth and Resistance to TMZ Through PTEN Pathway.
Liao Y; Shen L; Zhao H; Liu Q; Fu J; Guo Y; Peng R; Cheng L
J Cell Biochem; 2017 Jul; 118(7):1889-1899. PubMed ID: 28121023
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
[TBL] [Abstract][Full Text] [Related]
5. LncRNA XIST Promotes Pancreatic Cancer Proliferation Through miR-133a/EGFR.
Wei W; Liu Y; Lu Y; Yang B; Tang L
J Cell Biochem; 2017 Oct; 118(10):3349-3358. PubMed ID: 28295543
[TBL] [Abstract][Full Text] [Related]
6. Long non‑coding RNA CASC2 suppresses pancreatic cancer cell growth and progression by regulating the miR‑24/MUC6 axis.
Xu DF; Wang LS; Zhou JH
Int J Oncol; 2020 Feb; 56(2):494-507. PubMed ID: 31894271
[TBL] [Abstract][Full Text] [Related]
7. CBX7 suppresses cell proliferation, migration, and invasion through the inhibition of PTEN/Akt signaling in pancreatic cancer.
Ni S; Wang H; Zhu X; Wan C; Xu J; Lu C; Xiao L; He J; Jiang C; Wang W; He Z
Oncotarget; 2017 Jan; 8(5):8010-8021. PubMed ID: 28030829
[TBL] [Abstract][Full Text] [Related]
8. Positive feedback between lncRNA FLVCR1-AS1 and KLF10 may inhibit pancreatic cancer progression via the PTEN/AKT pathway.
Lin J; Zhai S; Zou S; Xu Z; Zhang J; Jiang L; Deng X; Chen H; Peng C; Zhang J; Shen B
J Exp Clin Cancer Res; 2021 Oct; 40(1):316. PubMed ID: 34635142
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of LncRNA NR027113 inhibits cell proliferation and metastasis via PTEN/PI3K/AKT signaling pathway in hepatocellular carcinoma.
Chen Z; Zhou ZY; He CC; Zhang JL; Wang J; Xiao ZY
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7222-7232. PubMed ID: 30468465
[TBL] [Abstract][Full Text] [Related]
10. Modulation of CASC2/miR-21/PTEN pathway sensitizes cervical cancer to cisplatin.
Feng Y; Zou W; Hu C; Li G; Zhou S; He Y; Ma F; Deng C; Sun L
Arch Biochem Biophys; 2017 Jun; 623-624():20-30. PubMed ID: 28495512
[TBL] [Abstract][Full Text] [Related]
11. ALKBH5-mediated m
He Y; Yue H; Cheng Y; Ding Z; Xu Z; Lv C; Wang Z; Wang J; Yin C; Hao H; Chen C
Cell Death Dis; 2021 Dec; 12(12):1121. PubMed ID: 34853296
[TBL] [Abstract][Full Text] [Related]
12. HIF‑1α‑induced upregulation of lncRNA UCA1 promotes cell growth in osteosarcoma by inactivating the PTEN/AKT signaling pathway.
Li T; Xiao Y; Huang T
Oncol Rep; 2018 Mar; 39(3):1072-1080. PubMed ID: 29328452
[TBL] [Abstract][Full Text] [Related]
13. Long non‑coding RNA CASC2 inhibits progression and predicts favorable prognosis in epithelial ovarian cancer.
Xue Z; Zhu X; Teng Y
Mol Med Rep; 2018 Dec; 18(6):5173-5181. PubMed ID: 30320385
[TBL] [Abstract][Full Text] [Related]
14. Deregulation of lncRNA-AC078883.3 and microRNA-19a is involved in the development of chemoresistance to cisplatin via modulating signaling pathway of PTEN/AKT.
Xing S; Qu Y; Li C; Huang A; Tong S; Wu C; Fan K
J Cell Physiol; 2019 Dec; 234(12):22657-22665. PubMed ID: 31111480
[TBL] [Abstract][Full Text] [Related]
15. Long Noncoding RNA HOTAIR Promotes Endometrial Carcinoma Cell Proliferation by Binding to PTEN via the Activating Phosphatidylinositol 3-Kinase/Akt Signaling Pathway.
Zhang XH; Hu P; Xie YQ; Kang YJ; Li M
Mol Cell Biol; 2019 Dec; 39(23):. PubMed ID: 31527078
[TBL] [Abstract][Full Text] [Related]
16. LncRNA CASC2 inhibits astrocytic activation and adenosine metabolism by regulating PTEN in pentylenetetrazol-induced epilepsy model.
Zhu H; Xu H; Ma H; Luo L; Yang L; Chen F; Qu X; Liu H; Zhang R
J Chem Neuroanat; 2020 Apr; 105():101749. PubMed ID: 31958564
[TBL] [Abstract][Full Text] [Related]
17. Long Noncoding RNA FAL1 Promotes Cell Proliferation, Invasion and Epithelial-Mesenchymal Transition Through the PTEN/AKT Signaling Axis in Non-Small Cell Lung Cancer.
Pan C; Yao G; Liu B; Ma T; Xia Y; Wei K; Wang J; Xu J; Chen L; Chen Y
Cell Physiol Biochem; 2017; 43(1):339-352. PubMed ID: 28854421
[TBL] [Abstract][Full Text] [Related]
18. Mutations in GAS5 affect the transformation from benign prostate proliferation to aggressive prostate cancer by affecting the transcription efficiency of GAS5.
Zhu L; Zhu Q; Wen H; Huang X; Zheng G
J Cell Physiol; 2019 Jun; 234(6):8928-8940. PubMed ID: 30317620
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA GPR65-1 is up-regulated in gastric cancer and promotes tumor growth through the PTEN-AKT-slug signaling pathway.
Li Y; Shen Z; Wang B; Ye C; Lai Z; Jiang H; Wang Z; Jiang K; Ye Y; Wang S
Cell Cycle; 2018; 17(6):759-765. PubMed ID: 29336198
[TBL] [Abstract][Full Text] [Related]
20. LncRNA LINC00641 predicts prognosis and inhibits bladder cancer progression through miR-197-3p/KLF10/PTEN/PI3K/AKT cascade.
Li Z; Hong S; Liu Z
Biochem Biophys Res Commun; 2018 Sep; 503(3):1825-1829. PubMed ID: 30060954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
